- Cambridge, Mass.-based Sarepta Therapeutics’ drug eteplirsen represents the first approved treatment for Duchenne’s muscular dystrophy.
- Lomaira is intended to help obese and overweight patients lose weight.
- India-based AuroBindo Pharma’s drug dolutegravir is intended to treat patients with HIV.
- Kyleena is a T-shaped intrauterine device that releases levonorgestrel, a hormone that stops the womb lining from thickening and consequently prevents pregnancy.
- Taiwan-based Medeon Biodesign developed a port site closure device called AbClose.
- Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR may now be used as a first-line treatment to improve glycemic control in diabetic adults.
More articles on supply chain:
Supply chain tip of the week: Stick to facts not feelings
Wireless diagnostic device can detect flu strains within minutes
Self-directed robots are the new warehouse workers
